These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 33122288)

  • 1. Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Schrauben SJ; Shou H; Zhang X; Anderson AH; Bonventre JV; Chen J; Coca S; Furth SL; Greenberg JH; Gutierrez OM; Ix JH; Lash JP; Parikh CR; Rebholz CM; Sabbisetti V; Sarnak MJ; Shlipak MG; Waikar SS; Kimmel PL; Vasan RS; Feldman HI; Schelling JR;
    J Am Soc Nephrol; 2021 Jan; 32(1):115-126. PubMed ID: 33122288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Biomarkers of Tubular Injury and Inflammation Are Associated with CKD Progression in Children.
    Greenberg JH; Abraham AG; Xu Y; Schelling JR; Feldman HI; Sabbisetti VS; Gonzalez MC; Coca S; Schrauben SJ; Waikar SS; Ramachandran VS; Shlipak MG; Warady B; Kimmel PL; Bonventre JV; Denburg M; Parikh CR; Furth S;
    J Am Soc Nephrol; 2020 May; 31(5):1067-1077. PubMed ID: 32234829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of Plasma Biomarkers of Inflammation, Fibrosis, and Kidney Tubular Injury With Progression of Diabetic Kidney Disease: A Cohort Study.
    Gutiérrez OM; Shlipak MG; Katz R; Waikar SS; Greenberg JH; Schrauben SJ; Coca S; Parikh CR; Vasan RS; Feldman HI; Kimmel PL; Cushman M; Bonventre JV; Sarnak MJ; Ix JH
    Am J Kidney Dis; 2022 Jun; 79(6):849-857.e1. PubMed ID: 34752914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease.
    Coca SG; Nadkarni GN; Huang Y; Moledina DG; Rao V; Zhang J; Ferket B; Crowley ST; Fried LF; Parikh CR
    J Am Soc Nephrol; 2017 Sep; 28(9):2786-2793. PubMed ID: 28476763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Biomarkers and Incident CKD Among Individuals Without Diabetes.
    Le D; Chen J; Shlipak MG; Ix JH; Sarnak MJ; Gutierrez OM; Schelling JR; Bonventre JV; Sabbisetti VS; Schrauben SJ; Coca SG; Kimmel PL; Vasan RS; Grams ME; Parikh C; Coresh J; Rebholz CM;
    Kidney Med; 2023 Nov; 5(11):100719. PubMed ID: 37841418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial.
    Sen T; Li J; Neuen BL; Neal B; Arnott C; Parikh CR; Coca SG; Perkovic V; Mahaffey KW; Yavin Y; Rosenthal N; Hansen MK; Heerspink HJL
    Diabetologia; 2021 Oct; 64(10):2147-2158. PubMed ID: 34415356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Biomarkers as Risk Factors for Incident CKD.
    Sarnak MJ; Katz R; Ix JH; Kimmel PL; Bonventre JV; Schelling J; Cushman M; Vasan RS; Waikar SS; Greenberg JH; Parikh CR; Coca SG; Sabbisetti V; Jogalekar MP; Rebholz C; Zheng Z; Gutierrez OM; Shlipak MG
    Kidney Int Rep; 2022 Jul; 7(7):1493-1501. PubMed ID: 35812266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.
    Malhotra R; Katz R; Jotwani V; Ambrosius WT; Raphael KL; Haley W; Rastogi A; Cheung AK; Freedman BI; Punzi H; Rocco MV; Ix JH; Shlipak MG
    Clin J Am Soc Nephrol; 2020 Mar; 15(3):349-358. PubMed ID: 32111704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine Biomarkers of Kidney Tubule Health, Injury, and Inflammation are Associated with Progression of CKD in Children.
    Greenberg JH; Abraham AG; Xu Y; Schelling JR; Feldman HI; Sabbisetti VS; Ix JH; Jogalekar MP; Coca S; Waikar SS; Shlipak MG; Warady BA; Vasan RS; Kimmel PL; Bonventre JV; Denburg M; Parikh CR; Furth S; ;
    J Am Soc Nephrol; 2021 Oct; 32(10):2664-2677. PubMed ID: 34544821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary Biomarkers of Tubular Health and Risk for Kidney Function Decline or Mortality in Diabetes.
    Chen TK; Coca SG; Thiessen-Philbrook HR; Heerspink HJL; Obeid W; Ix JH; Fried LF; Bonventre JV; El-Khoury JM; Shlipak MG; Parikh CR;
    Am J Nephrol; 2022; 53(11-12):775-785. PubMed ID: 36630924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Soluble Urokinase Plasminogen Activator Receptor (suPAR) and CKD Progression in Children.
    Weidemann DK; Abraham AG; Roem JL; Furth SL; Warady BA
    Am J Kidney Dis; 2020 Aug; 76(2):194-202. PubMed ID: 31987488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes.
    Pena MJ; Heinzel A; Heinze G; Alkhalaf A; Bakker SJ; Nguyen TQ; Goldschmeding R; Bilo HJ; Perco P; Mayer B; de Zeeuw D; Lambers Heerspink HJ
    PLoS One; 2015; 10(5):e0120995. PubMed ID: 25973922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants.
    Nadkarni GN; Chauhan K; Verghese DA; Parikh CR; Do R; Horowitz CR; Bottinger EP; Coca SG
    Kidney Int; 2018 Jun; 93(6):1409-1416. PubMed ID: 29685497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Serum Soluble Urokinase Receptor Levels With Progression of Kidney Disease in Children.
    Schaefer F; Trachtman H; Wühl E; Kirchner M; Hayek SS; Anarat A; Duzova A; Mir S; Paripovic D; Yilmaz A; Lugani F; Arbeiter K; Litwin M; Oh J; Matteucci MC; Gellermann J; Wygoda S; Jankauskiene A; Klaus G; Dusek J; Testa S; Zurowska A; Caldas Afonso A; Tracy M; Wei C; Sever S; Smoyer W; Reiser J;
    JAMA Pediatr; 2017 Nov; 171(11):e172914. PubMed ID: 28873129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease.
    Waijer SW; Sen T; Arnott C; Neal B; Kosterink JGW; Mahaffey KW; Parikh CR; de Zeeuw D; Perkovic V; Neuen BL; Coca SG; Hansen MK; Gansevoort RT; Heerspink HJL
    Clin J Am Soc Nephrol; 2022 Feb; 17(2):251-259. PubMed ID: 34876454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of Kidney Tubular Biomarkers With Incident Macroalbuminuria and Sustained Low eGFR in DCCT/EDIC.
    Limonte CP; Gao X; Bebu I; Seegmiller JC; Karger AB; Lorenzi GM; Molitch M; Karanchi H; Perkins BA; de Boer IH; ;
    Diabetes Care; 2024 Sep; 47(9):1539-1547. PubMed ID: 38484321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD.
    Luo S; Coresh J; Tin A; Rebholz CM; Chen TK; Hayek SS; Tracy M; Lipkowitz MS; Appel LJ; Levey AS; Inker LA; Reiser J; Grams ME
    Clin J Am Soc Nephrol; 2018 Jul; 13(7):1013-1021. PubMed ID: 29903900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of Kidney Tubule Disease and Risk of End-Stage Kidney Disease in Persons With Diabetes and CKD.
    Amatruda JG; Katz R; Sarnak MJ; Gutierrez OM; Greenberg JH; Cushman M; Waikar S; Parikh CR; Schelling JR; Jogalekar MP; Bonventre JV; Vasan RS; Kimmel PL; Shlipak MG; Ix JH;
    Kidney Int Rep; 2022 Jul; 7(7):1514-1523. PubMed ID: 35812302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.